Evaluating safety and pharmacokinetics of TPM XR as adjunctive therapy in pediatric epilepsy

Seizures are abnormal electrical impulses in the brain. The signs and symptoms of seizures vary depending on the type of seizure a patient has. This study is looking at the use of an extended release form of topiramate in pediatric patients with epilepsy

Medication Under Study:
topiramate extended release (TPM XR)

Full study title:
Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as
Adjunctive Therapy in Pediatric Subjects with Epilepsy

IRB Study ID:

Who may qualify:

Patients ages 4-17 with a diagnosis of epilepsy currently being treated with topiramate

Who does not qualify:

Patients with certain medical conditions or taking certain medications

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

For urgent patient care matters involving a current study patient, please call: 330-920-5774

Lead Principal Investigator:

Thomas Enlow, MD
Pediatric Neurologist

Bookmark and Share

iGrow iGrow
Sign up for our parent enewsletter
    Contact Us



    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.